JPRN-UMIN000011234招募中2 期
Phase II study of R-mini CHP for elderly patients with diffuse large B cell lymphoma - R-mini CHP
Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)0 个研究点目标入组 40 人开始时间: 2013年7月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 80years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.presence of active infeciton 2.presence of central nervous invasion 3.past history of glaucoma. 4.past history of severe drug allergy. 5.HIV Ab positive or HTLV-1 Ab positive. 6.HBsAg positive or HCV Ab positive. 7.severe cardiac disease 8.hepatic cirrhosis 9.uncontrollable diabetis melitus 10.patients with dialysis 11.lung fibrosis or interstitial pneumonitis 12.other active malignancies 13.pregnant or feeding female 14.severe mental disorder 15.continuous systemic administration of steroid 16.judged for inappropriate with other reasons
研究者
相似试验
已完成
2 期
Mini-CHOP and Rituximab in Patients Aged Over 80 YearsDiffuse Large B-Cell LymphomaNCT01087424Lymphoma Study Association150
进行中（未招募）
不适用
A phase II study of Cloretazine for elderly patients with de novo poor risk acute myelogenous leukemia.Acute Myelogenous LeukemiaEUCTR2006-001853-89-GBVion Pharmaceuticals, Inc85
进行中（未招募）
不适用
A phase II study of Cloretazine for elderly patients with de novo poor risk acute myelogenous leukemia.Acute Myelogenous LeukemiaMedDRA version: 8.1Level: LLTClassification code 10000886Term: Acute myeloid leukemiaEUCTR2006-001853-89-DEVion Pharmaceuticals, Inc85
招募中
不适用
Phase II study of S-1 chemotherapy in elderly patients with advanced non-small cell lung cancer harboring no EGFR gene mutatioon-small cell lung cancerJPRN-UMIN000005058Respiratory Center, Asahikawa Medical University Hospital30
已完成
不适用
Sorafenib in Elderly mRCCCarcinoma, Renal CellNCT01728948Bayer60